GHRS
Price
$13.96
Change
+$0.34 (+2.49%)
Updated
Aug 28, 11:25 AM (EDT)
Capitalization
830.57M
70 days until earnings call
IBRX
Price
$2.38
Change
+$0.04 (+1.71%)
Updated
Aug 28, 11:29 AM (EDT)
Capitalization
2.21B
71 days until earnings call
Interact to see
Advertisement

GHRS vs IBRX

Header iconGHRS vs IBRX Comparison
Open Charts GHRS vs IBRXBanner chart's image
GH Research
Price$13.96
Change+$0.34 (+2.49%)
Volume$100
Capitalization830.57M
ImmunityBio
Price$2.38
Change+$0.04 (+1.71%)
Volume$1.1K
Capitalization2.21B
GHRS vs IBRX Comparison Chart in %
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. IBRX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and IBRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (GHRS: $13.63 vs. IBRX: $2.34)
Brand notoriety: GHRS and IBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 74% vs. IBRX: 76%
Market capitalization -- GHRS: $830.57M vs. IBRX: $2.21B
GHRS [@Biotechnology] is valued at $830.57M. IBRX’s [@Biotechnology] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 1 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • GHRS’s FA Score: 1 green, 4 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, GHRS is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 3 TA indicator(s) are bullish while IBRX’s TA Score has 2 bullish TA indicator(s).

  • GHRS’s TA Score: 3 bullish, 5 bearish.
  • IBRX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, GHRS is a better buy in the short-term than IBRX.

Price Growth

GHRS (@Biotechnology) experienced а +6.65% price change this week, while IBRX (@Biotechnology) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.76%. For the same industry, the average monthly price growth was +15.41%, and the average quarterly price growth was +31.52%.

Reported Earning Dates

GHRS is expected to report earnings on Nov 06, 2025.

IBRX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.21B) has a higher market cap than GHRS($831M). GHRS YTD gains are higher at: 94.714 vs. IBRX (-8.594). GHRS has higher annual earnings (EBITDA): -40.66M vs. IBRX (-237.93M). GHRS has more cash in the bank: 292M vs. IBRX (154M). GHRS has less debt than IBRX: GHRS (647K) vs IBRX (535M). IBRX has higher revenues than GHRS: IBRX (56.6M) vs GHRS (0).
GHRSIBRXGHRS / IBRX
Capitalization831M2.21B38%
EBITDA-40.66M-237.93M17%
Gain YTD94.714-8.594-1,102%
P/E RatioN/AN/A-
Revenue056.6M-
Total Cash292M154M190%
Total Debt647K535M0%
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSIBRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MYSPX69.120.16
+0.23%
NYLI S&P 500 Index Investor Class
LSOFX18.72N/A
N/A
LS Opportunity Fund Institutional Class
TICHX29.44N/A
N/A
Nuveen Large Cap Responsible Eq I
JHERX20.11N/A
N/A
JHancock Equity Income C
VSQFX18.29N/A
N/A
Invesco MSCI World SRI Index R5

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
+1.79%
MDGL - GHRS
43%
Loosely correlated
+0.05%
IVVD - GHRS
37%
Loosely correlated
-15.44%
ATAI - GHRS
34%
Loosely correlated
-5.38%
ATHE - GHRS
32%
Poorly correlated
-0.60%
IBRX - GHRS
31%
Poorly correlated
-1.68%
More

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
-1.68%
AXON - IBRX
48%
Loosely correlated
+0.09%
ARRY - IBRX
41%
Loosely correlated
-5.54%
CLRB - IBRX
40%
Loosely correlated
+1.26%
RXRX - IBRX
40%
Loosely correlated
+1.24%
SYRE - IBRX
39%
Loosely correlated
+0.47%
More